Ansell, S. M., Maurer, M. J., Ziesmer, S. C., Slager, S. L., Habermann, T. M., Link, B. K., . . . Novak, A. J. (2012). Elevated Pretreatment Serum Levels of Interferon-inducible Protein-10 (CXCL10) Predict Disease Relapse and Prognosis in Diffuse Large B-Cell Lymphoma Patients.
Citación estilo ChicagoAnsell, Stephen M., et al. Elevated Pretreatment Serum Levels of Interferon-inducible Protein-10 (CXCL10) Predict Disease Relapse and Prognosis in Diffuse Large B-Cell Lymphoma Patients. 2012.
Cita MLAAnsell, Stephen M., et al. Elevated Pretreatment Serum Levels of Interferon-inducible Protein-10 (CXCL10) Predict Disease Relapse and Prognosis in Diffuse Large B-Cell Lymphoma Patients. 2012.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.